Regulation of splenic monocyte homeostasis and function by gut microbial products

Splenic Ly6C(high) monocytes are innate immune cells involved in the regulation of central nervous system-related diseases. Recent studies have reported the shaping of peripheral immune responses by the gut microbiome via mostly unexplored pathways. In this study, we report that a 4-day antibiotic treatment eliminates certain families of the Bacteroidetes, Firmicutes, Tenericutes, and Actinobacteria phyla in the gut and reduces the levels of multiple pattern recognition receptor (PRR) ligands in the serum. Reduction of PRR ligands was associated with reduced numbers and perturbed function of splenic Ly6C(high) monocytes, which acquired an immature phenotype producing decreased levels of inflammatory cytokines and exhibiting increased phagocytic and anti-microbial abilities. Addition of PRR ligands in antibiotic-treated mice restored the number and functions of splenic Ly6Chigh monocytes. Our data identify circulating PRR ligands as critical regulators of the splenic Ly6C(high) monocyte behavior and suggest possible intervention pathways to manipulate this crucial immune cell subset.

Automated summary

This study demonstrates that antibiotic treatment can eliminate certain bacterial families in the gut, leading to a decrease in PRR ligands and affecting the quantity and function of splenic Ly6C(high) monocytes. Addition of PRR ligands can restore the function of these monocytes.